Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception

Evaluation of mental and emotional state of patients with polycystic ovary syndrome on the background of hormonal contraception

Goal. The study of changes in mental and emotional state in patients with polycystic ovarian syndrome before you start taking a hormonal contraceptive containing estradiol valerate (E2V) in combination with dienogest (DNG) in dynamic mode and after 12 months against a background of continued adminis...

Full description

Bibliographic Details
Main Authors:	T Iu Pestrikova, E A Iurasova, E L Sukhonosova
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2016-08-01
Series:	Гинекология
Subjects:	polycystic ovary syndrome hyperandrogenism estradiol valerate combined with dienogest assessment of mental and emotional state
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28556/pdf

Similar Items

Hydro-alcoholic extract of Ziziphora tenuior L. on polycystic ovary syndrome in Wistar rats
by: Mohammad Nabiuni, et al.
Published: (2015-08-01)

Estradiol Valerate-induced Polycystic Ovary Syndrome: An Animal Model Study
by: F Mesbah, et al.
Published: (2011-01-01)

Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels
by: Stephanie Mohammed, et al.
Published: (2021-12-01)

Estradiol valerate improves endometrial receptivity induced by clomiphene in rat with polycystic ovary syndrome
by: SHAO Rui-feng, HE Chi-hua, WANG Ying
Published: (2020-01-01)

Thymoquinone ameliorates some endocrine parameters and histological alteration in a rat model of polycystic ovary syndrome
by: Sima Taghvaee Javanshir, et al.
Published: (2018-04-01)

Heart Rate Changes in Electroacupuncture Treated Polycystic Ovary in Rats
by: Mukilan Ramadoss, et al.
Published: (2016-03-01)

Changes in the Expression of Cyclooxygenase-2 in Polycystic Ovary Syndrome in Wistar Rats
by: Karimzadeh L, et al.
Published: (2011-12-01)

Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate
by: Ghadire Mirabolghasemi, et al.
Published: (2017-04-01)

Contraception with estradiol valerate and dienogest: adherence to the method
by: Fruzzetti F, et al.
Published: (2019-05-01)

Effective treatment of different types of polycystic ovary syndrome in adolescent girls
by: E. V. Uvarova, et al.
Published: (2022-01-01)

Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries
by: Atis Alev, et al.
Published: (2012-02-01)

Combined oral contraceptives with shortened hormone-free interval. Proven advantages of the therapy regime
by: G. B. Dikke
Published: (2019-10-01)

Estradiol valerate and dienogest in hormonal contraception. Acceptability and effectiveness in real clinical practice
by: E. R. Dovletkhanova, et al.
Published: (2018-09-01)

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study
by: Briggs P, et al.
Published: (2016-09-01)

Therapeutic effects of aqueous extract of bioactive active component of Ageratum conyzoides on the ovarian-uterine and hypophysis-gonadal axis in rat with polycystic ovary syndrome: Histomorphometric evaluation and biochemical assessment
by: Sunday Aderemi Adelakun, et al.
Published: (2022-09-01)

Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats
by: Stephanie Mohammed, et al.
Published: (2021-02-01)

Real clinical practice and contraception for young women with children
by: Natalia V. Aganezova, et al.
Published: (2021-03-01)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01)

Anti-Müllerian hormone in polycystic ovary syndrome and normo-ovulatory women: Correlation with clinical, hormonal and ultrasonographic parameters
by: Adel F. Begawy, et al.
Published: (2010-10-01)

Markers of hyperandrogenism in South Asians with polycystic ovary syndrome
by: WMM Boteju, et al.
Published: (2014-08-01)

Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?
by: Fruzzetti F, et al.
Published: (2018-11-01)

Polycystic ovary syndrome and immune deregulation: what do hormones want to say?
by: Betcy Susan Johnson, et al.
Published: (2022-06-01)

Major Epigenetic Changes in Polycystic Ovary Syndrome
by: Tara Akhtarkhavari, et al.
Published: (2022-09-01)

Frequency of Hyperandrogenism in Females with Polycystic Ovary Syndrome
by: Sumera Mehnaz, Rahat Akhtar, Nadia Taj
Published: (2021-11-01)

Clinical, biochemical and hormone profile in hirsute vs nonhirsute patients with polycystic ovary syndrome
by: Iram Shabir, et al.
Published: (2020-07-01)

An Investigation of Biochemical and Structural Changes in Reproductive System Hyperandrogenism in Experimental Letrozole-induced Polycystic Ovary Syndrome in Rat
by: Azam Soleimani, et al.
Published: (2016-11-01)

Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
by: Zaixin Guo, et al.
Published: (2023-04-01)

Analysis of the informativeness of melatonin evaluation in polycystic ovary syndrome
by: Elena Andreeva, et al.
Published: (2016-12-01)

Kymographic characteristics of voice in women with Polycystic ovary syndrome
by: Saranya Blahayil, et al.
Published: (2021-06-01)

MENORRHAGIA: ARE THERE ANY SOLUTIONS?
by: Y. E. Dobrokhotova, et al.
Published: (2016-12-01)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
by: Lin Lin, et al.
Published: (2015-01-01)

MODERN CONCEPTS OF THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME (LITERATURE REVIEW)
by: O. V. Panarina, et al.
Published: (2017-07-01)

The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
by: Mala S. Sivanandy, et al.
Published: (2023-02-01)

The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D
by: A. M. Maysara, et al.
Published: (2020-04-01)

Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
by: Mina Amiri, et al.
Published: (2022-03-01)

Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms
by: Nada Ahmed, et al.
Published: (2019-10-01)

Self-Administered Questionnaire to Screen for Polycystic Ovarian Syndrome
by: Bronwyn S. Bedrick, et al.
Published: (2020-12-01)

An update of polycystic ovary syndrome: causes and therapeutics options
by: Abeer M. Rababa’h, et al.
Published: (2022-10-01)

Effect of combined oral contraceptives with estrogen identical to natural estrogen on the metabolic profile and body composition in females during the menopausal transition
by: Veronika I. Komedina, et al.
Published: (2023-01-01)

The Relation Between Free Testosterone and Components of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
by: Zahra Abbasi Ranjbar, et al.
Published: (2018-08-01)